Clinical Trial Update: Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update on NRL972 shows pharmacokinetic clearance in patients with cirrhosis and in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver

Drugs mentioned

• NRL972 (NRL972)

Snippet

Sponsor: Norgine | Conditions: Hepatic Cirrhosis | Phase 1 | Status: COMPLETED